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Abstract
The herpes simplex virus type 1 (HSV-1) latency associated transcript (LAT) gene's anti-apoptosis activity plays a central, but not fully
elucidated, role in enhancing the virus's reactivation phenotype. In transient transfection experiments, LAT increases cell survival following an
apoptotic insult in the absence of other HSV-1 genes. However, the high background of untransfected cells has made it difficult to demonstrate that
LAT inhibits specific apoptotic factors such as caspases. Here we report that, in mouse neuroblastoma cell lines (C1300) stably expressing high
levels of LAT, cold shock induced apoptosis was blocked as judged by increased survival, protection against DNA fragmentation (by DNA ladder
assay), and inhibition of caspase 3 cleavage and activation (Western blots). To our knowledge, this is the first report providing direct evidence that
LAT blocks two biochemical hallmarks of apoptosis, caspase 3 cleavage and DNA laddering, in the absence of other HSV-1 gene products.
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cause of corneal blindness due to an infectious agent (Nesburn,
1983). HSV-1 induced corneal blindness results from corneal
scarring, most of which is due to recurrent rather than primary
infection. HSV-1 also causes cold sores in and around the
mouth, genital herpes, and encephalitis. Estimates are that 60–
90% of the adult US population harbors latent HSV-1 or HSV-2
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doi:10.1016/j.virol.2007.07.023severe herpetic disease is due to recurrent rather than primary
disease. Understanding the molecular mechanisms by which the
HSV-1 latency-reactivation cycle is regulated is therefore
important for the eventual control and elimination of herpetic
disease. During primary infection at a peripheral mucosal site,
the virus enters sensory nerves, travels up the nerves to the
ganglionic nerve bodies, and establishes a latent infection. The
virus can reactivate sporadically throughout the life of the
infected individual, return to and be shed at the original
peripheral site, and cause recurrent disease.
During neuronal latency, a single HSV-1 gene, the latency
associated transcript, or LAT gene, is abundantly transcribed
(Rock et al., 1987; Stevens et al., 1987). LAT null mutants have a
significantly reduced reactivation phenotype in small animal
models indicating that LAT plays an important role in enhancing
13D. Carpenter et al. / Virology 369 (2007) 12–18the virus's reactivation phenotype (Block et al., 1993; Bloom
et al., 1994; Devi-Rao et al., 1994; Leib et al., 1989; Perng et al.,
1994, 2001; Trousdale et al., 1991). Although it is not yet clear
exactly how LAT enhances the reactivation phenotype, recent
work indicates that LAT has anti-apoptosis activity and that this
anti-apoptosis activity is important (Ahmed et al., 2002; Branco
and Fraser, 2005; Gupta et al., 2006; Henderson et al., 2002;
Inman et al., 2001; Jin et al., 2003, 2005; Mott et al., 2003; Peng
et al., 2004; Perng et al., 2000, 2002). The first 1.5 kb of LAT
which is approximately the first 18% of the primary LAT
transcript, is sufficient for supporting a wild type virus
reactivation phenotype (Perng et al., 1996a). The same LAT
region can interfere with apoptosis as efficiently as much
longer stretches of LAT (Inman et al., 2001; Peng et al., 2004).
Thus LAT's anti-apoptosis activity and LAT's ability to enhance
the reactivation phenotype co-map, suggesting a functional
relationship. In addition, viruses in which the functional region
of LAT has been replaced by an alternative anti-apoptosis
gene have a LAT(+) wild type reactivation phenotype (Jin et al.,
2005; Perng et al., 2002). These findings indicate that LAT's
anti-apoptosis function is involved in how LAT enhances the
HSV-1 reactivation phenotype.
Studying the mechanism, or even the steps in the apoptosis
pathway that are affected by LAT has been limited to either
studies using LAT(+) versus LAT(-) virus infected animals or
cells, or transient transfection assays in tissue culture. The
former is complicated by the fact that several HSV-1 genes other
than LAT can affect apoptosis (Aubert and Blaho, 1999; Galvan
et al., 1999; Galvan and Roizman, 1998; Leopardi et al., 1997;
Zhou et al., 2000). The latter is complicated by the high
background of untransfected cells present in cell cultures
following transient transfection. One obvious solution would be
to study LAT's anti-apoptosis activity in a cell line in which
LAT is stably expressed, thus eliminating background problems
due to cells not expressing LAT, while also isolating LAT from
other viral gene products. We have taken this approach here.Fig. 1. Schematic diagram of the cloned LAT region expressed in stable C1300 cell li
promoter nts −361 to +1 followed by the first 3225 nts of the primary LAT transcr
DC-LAT2, DC-LAT6, and DC-LAT11. The LAT RNA expressed is shown under th
corresponding to LAT nts −130 to +64. This deletion removes essential LAT promo
(dashed lines). This plasmid was used to generate DC-ΔLAT35 and DC-ΔLAT311We report here the construction and the preliminary
characterization of stable C1300 derived cell lines that express
high levels of LAT. In addition, we show that compared to
similar LAT(−) cells that contain the same plasmid and the
same LAT coding region, but without a promoter, the LAT(+)
cells are refractory to death following cold shock. Furthermore,
cell death following cold shock was due to apoptosis as judged
by DNA fragmentation assays (DNA laddering) and by
caspase 3 activation (caspase 3 cleavage by Western analysis),
both of which were inhibited in the high expression LAT(+)
cells.
Results
Establishment of C1300 cells stably expressing high levels of
LAT
pLNotI contains a NotI–NotI restriction fragment corre-
sponding to LAT nts −361 to +3225 and thus contains 361 nts
of the LAT promoter followed by the first 3225 nts of the
primary LAT transcript (+1 to +3225) (Fig. 1). It can therefore
efficiently transcribe the first 3225 nts of the primary LAT
transcript (indicated by the transcript under the plasmid in Fig.
1). pLNotIΔPstI was derived from pLNotI by removing a PstI–
PstI restriction fragment corresponding to LAT nts −130 to
+64. This removed a critical region of the LAT promoter,
including the LAT TATA box, and the start site of RNA
transcription, rendering the plasmid extremely restricted for
transcribing LAT RNA (Fig. 1; dashed lines). Three stable cell
lines containing pLNotI (DC-LAT2, DC-LAT6, DC-LAT11)
and two cell lines containing pLNotIΔPstI (DC-ΔLAT35 and
DC-ΔLAT311) were generated using mouse neuroblastoma
C1300 cells.
Northern blots using a LAT derived BspMI–HpaI probe
specific for the 2 kb LAT, detected a band from DC-LAT2, DC-
LAT6, and DC-LAT11 cells, indicating that these cell lines eachnes. (A) pLNotI, a 3586 bp NotI–NotI DNA restriction fragment containing LAT
ipt (+1 to +3225). This restriction fragment was used to generate the cell lines
e plasmid. (B) pLNotIΔPstI is identical to pLNotI but with a PstI–PstI deletion
ter elements including the LAT TATA box and no detectable LAT RNA is made
cells. Sd=Splice donor; Sa=Spice acceptor.
Fig. 3. Cell survival following cold shock. Each cell line was plated into 6 T25
flasks and allowed to recover overnight in a 37 °C CO2 incubator. The next day,
the flasks were tightly capped. Three flasks of each cell line were incubated for
2 h on ice (cold shocked) and 3 flasks of each cell line were incubated at 37 °C
without CO2 (not cold shocked). After 2 h, the caps were loosened and all flasks
were returned to a 37 °C CO2 incubator to recover for 4 h. After treatment, the
cells were washed once, trypsinized, and the number of cells that had remained
attached was determined using a hemacytometer. The bars represent the average
of 3 repeats±SD. The numbers above each bar indicate the percent of cells after
cold shock [(cold shock/no cold shock)×100%] for each cell line. The results
for each cell line are representative of at least 3 independent experiments.
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specific probe co-migrated with 18S ribosomal RNA (detected
by ethidium bromide staining) which migrates with an apparent
size of approximately 2 kb. Also as expected, no LAT RNAwas
detected in parental C1300 cells, in DC-ΔLAT311 (Fig. 2) or
DC-ΔLAT35 (not shown). DC-LAT6, which had the highest
LAT RNA levels, was chosen as the main LAT positive cell line
for further studies. No primary LAT transcript corresponding to
an unspliced 3.2 kb primary transcript was detected using the
above 2 kb LAT specific probe even upon overexposure. The
primary transcript was also not detected using a StyI–StyI probe
(corresponding to LAT nts 76–447) specific for LAT exon 1.
The ability to detect the 2 kb LAT intron but not the primary
transcript encoded by the plasmid is not surprising because
during both latent and acute infection the 2 kb LAT is stable and
easily detected by Northern blots, while the much less stable
primary 8.3 kb LAT transcript is not.
The amount of 2 kb LAT present in DC-LAT2, DC-LAT6,
and DC-ΔLAT311 cells was estimated by real-time RT-PCR
and compared to the amount of 2 kb LAT we detected 7 h after
acute infection with 3 PFU/cell of wild type (strain 17syn+)
HSV-1. Acutely infected cells and the high LATexpressing DC-
LAT6 cells had an average of 564 and 597 copies of LAT RNA/
cell. In contrast, the DC-LAT2 cells which appeared to have
much less LAT by Northern blot (see Fig. 2) had 131 copies/
cell. As expected, C1300 cells and the LAT negative DC-
ΔLAT311 cells had no detectable LAT.
Cold shock
It was recently reported that transient transfection of SY5Y
cells with a LAT expressing plasmid protected the cells fromFig. 2. Northern blot of LAT-RNA in stable C1300 derived cell lines. Total RNA
was isolated from cells and analyzed by Northern blot using a probe specific for
the stable 2 kb LAT intron as described in Materials and methods. The cell lines
are indicated at the top. The arrow indicates the location of 18S ribosomal RNA
(with an apparent mobility of 2 kb) based on ethidium bromide staining.cold stress (Atanasiu et al., 2006). To determine how DC-LAT6
cells reacted to cold, we cold shocked DC-LAT6, DC-
ΔLAT311, and parental C1300 cells on ice for 2 h and returned
them to 37 °C for 4 h. Many more DC-LAT6 compared to DC-
ΔLAT311 cells and C1300 cells appeared to survive the cold
shock/recovery period as judged by phase contrast microscopy
(not shown). To quantitate the number of cells that remained
adherent, the monolayers were rinsed, trypsinized, and the
number of cells that were attached prior to trypsinization was
counted (Fig. 3). Following recovery from cold shock, the
number of attached LAT expressing DC-LAT6 cells was
significantly higher (∼2.5-fold) compared to the DC-
ΔLAT311 cells and C1300 cells (Pb0.001, ANOVA). Other
LAT(+) and LAT(−) expressing cells (DC-LAT11 and DC-
ΔLAT35; not shown) behaved similarly to DC-LAT6 and DC-
ΔLAT311, respectively. Thus, expression of LAT appeared to
provide significant protection against death of C1300 cells
following recovery from cold shock. Similar cell loss was seen
following UV induction of apoptosis (not shown). In addition,
we have previously shown that, in Neuro2A cells, a cell line
derived from the same neuroblastoma as C1300 cells and which
in our hands are very similar to C1300 cells, apoptosis can be
induced by numerous standard methods (Inman et al., 2001; Jin
et al., 2003; Peng et al., 2005, 2004; Perng et al., 2000). Note
that compared to no cold shock, cold shock appeared to have
slightly reduced the number of DC-LAT6 cells. This may have
been the result of a small amount of cell death during recovery
from cold shock.
Fig. 4. Decreased DNA laddering in LAT(+) cell lines following cold shock.
Cells were maintained at 37 °C, cold shocked for 2 h but not recovered, or cold
shocked for 2 h and recovered at 37 °C for 2 h as indicated. Fragmented
chromosomal DNA was isolated using a hypotonic buffer that releases
fragmented but not intact chromosomal DNA from the nucleus and equal
aliquots were run on a gel as described in Materials and methods.
Fig. 5. LAT(+) cell lines are protected against cold shock induced caspase 3
cleavage. Cells were maintained at 37 °C (left panel) cold shocked and harvested
immediately (middle panel) or allowed to recover for 2 h at 37 °C (right panel) as
described in Materials and methods. Western blotting was done using an
antibody specific for activated (cleaved) caspase 3 as described in Materials and
methods. (A) Cleaved caspase 3. (B) GAPDH loading controls.
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recovery from cold shock
C1300, DC-LAT6, DC-LAT11, and DC-ΔLAT311 cells
were maintained at 37 °C, cold shocked for 2 h and imme-
diately harvested, or cold shocked for 2 h and then recovered at
37 °C for 2 h. Fragmented DNA was isolated from the
monolayers as described in Materials and methods, run on an
agarose gel, and visualized by ethidium bromide staining (Fig.
4). Note that in this assay the harvested cells are incubated in
hypotonic buffer for 2 h at 4 °C. This lyses the cells without
disrupting the nuclei and allows fragmented DNA to be eluted
from the nuclei while leaving the large unfragmented
chromosomal DNA trapped inside the nucleus. The nuclei
(and unfragmented chromosomal DNA) are removed by
centrifugation and equal aliquots are subjected to electrophor-
esis. This results in both more “laddering” and more total
(fragmented) DNA in samples from apoptotic cultures, with
little or no intact chromosomal DNA at the top of the gel. A
typical apoptotic DNA laddering pattern was seen in the C1300
parental cells and in DC-ΔLAT311 cells. Much less DNA
laddering was seen in DC-LAT6 or DC-LAT11 cells. Little or
no DNA laddering was seen in any cell line maintained at 37 °Cor cold shocked with no 37 °C recovery. Thus, apoptosis
induced by recovery from cold shock in C1300 cells appeared
greatly inhibited by LAT.
LAT decreased cold shock induced caspase 3 cleavage in
C1300 cells
LAT(+) DC-LAT2, DC-LAT6, and DC-LAT11 cells, and
LAT(−) DC-ΔLAT311 cells were cold shocked as above and
either harvested immediately or allowed to recover for 2 h at
37 °C. Attached and unattached cells were pooled, total cell
extracts were prepared, and Western blots were performed using
an antibody specific for cleaved (activated) caspase 3 as
described in Materials and methods. At the exposure time
shown, little or no cleaved caspase 3 was detected in any of the
cells maintained at 37 °C or in any of the cells immediately after
2 h on ice (Fig. 5). However, after 2 h of recovery from cold
shock at 37 °C, cleaved caspase 3 appeared abundant in the LAT
(-) DC-ΔLAT311 cells compared to the high LAT expressing
DC-LAT6 and DC-LAT11 cells. As expected, DC-LAT2 cells,
which express less LAT than do the DC-LAT6 and DC-LAT11
cells (see Fig. 2), did not block caspase 3 cleavage as efficiently
as the DC-LAT6 and DC-LAT11 cells. Also as expected, the
DC-LAT2 cells had less cleaved caspase 3 than the LAT(−) DC-
ΔLAT311 cells. This confirmed that recovery from cold shock
induces apoptosis in C1300 cells not expressing LAT and that
high levels of LAT expression efficiently decreased cold shock
induced apoptosis. The apoptosis occurred during recovery
from cold shock rather than while cells were on ice, since
maintaining cells on ice for 4 h instead of 2 h did not alter
caspase 3 cleavage (not shown). These results suggest that there
is a minimum level of LAT expression required for efficient
blocking of caspase 3 cleavage. Thus, the ability of LAT to
block cold shock related apoptosis appeared to be dose
dependent, providing further evidence that LAT protects against
cold shock related apoptosis.
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The HSV-1 LAT gene is the only viral gene abundantly
expressed during neuronal latency (Rock et al., 1987;
Stevens et al., 1987). LAT plays an important role in the
reactivation phenotype since LAT(−) mutants have a
significantly reduced reactivation phenotype in small animal
models (Block et al., 1993; Bloom et al., 1994; Devi-Rao
et al., 1994; Leib et al., 1989; Perng et al., 1994, 2001;
Trousdale et al., 1991). LAT has anti-apoptosis activity
(Ahmed et al., 2002; Branco and Fraser, 2005; Gupta et al.,
2006; Henderson et al., 2002; Inman et al., 2001; Jin et al.,
2003, 2005; Mott et al., 2003; Peng et al., 2004; Perng et al.,
2000, 2002). The first 1.5 kb of the 8.3–8.5 kb primary LAT
transcript is sufficient and necessary for both enhancing the
reactivation phenotype and for efficiently interfering with
apoptosis (Inman et al., 2001; Perng et al., 1996a). In
addition, mutants in which the functional region of LAT was
replaced by an alternative anti-apoptosis gene have reactiva-
tion phenotypes at least equivalent to that of LAT(+) (wild
type) virus (Jin et al., 2005; Perng et al., 2002). Thus, at
least one of the mechanisms by which LAT enhances the
reactivation phenotype in small animal models is through its
anti-apoptosis activity.
Although we and others have reported that LAT can block
apoptosis, the studies that suggest that LAT can block activation
of caspases have been limited to comparisons using LAT(−)
versus LAT(+) viruses (Henderson et al., 2002, 2004). These
experiments by necessity were done in the presence of all 80+
herpes gene products, several of which have powerful anti-
apoptosis activity (Aubert and Blaho, 1999; Galvan et al., 1999;
Galvan and Roizman, 1998; Leopardi et al., 1997; Zhou et al.,
2000), thus potentially hindering interpretation of the results.
Previous studies of LAT in the absence of other viral proteins
have relied on indirect anti-apoptosis assays following transient
transfection of cells with LAT expressing plasmids. Although
these studies clearly showed that LAT plasmids can inhibit cell
death following various apoptotic insults (Branco and Fraser,
2005; Henderson et al., 2002; Inman et al., 2001; Jin et al.,
2003; Peng et al., 2004; Perng et al., 2000), the high
background from untransfected cells has not allowed analysis
of LAT's effect on apoptosis events such as DNA laddering or
caspase 3 cleavage. In contrast, by using stable LAT expressing
cells and thus eliminating high background problems, here we
were able to show that LAT in the absence of other HSV-1
genes can significantly decrease death, apoptotic DNA
fragmentation, and caspase 3 cleavage, thus directly demon-
strating for the first time that LAT expression in the absence of
other HSV-1 gene expression can block specific apoptotic
events.
Further standardization was achieved by using cold shock
to induce apoptosis. This is an extremely simple, highly
reproducible method in which a flask of cells is placed on ice
for 2 h and then returned to 37 °C. Variations between
chemical lots, solution preparations, and UV light sources that
are routinely used to induce apoptosis are therefore eliminated.
It should be noted that the use of C1300 cells was importanthere because cold shock does not induce apoptosis in all cell
lines.
It has recently been reported that LAT encodes a microRNA
(miRNA) from within LAT exon 1 that is capable of interfering
with apoptosis (Gupta et al., 2006). The region encoding this
miRNA is completely contained within the LAT expressed in
the stable cell lines in this report. However, we think this
miRNA is unlikely to be fully responsible for LAT's anti-
apoptosis activity since a plasmid expressing the full LAT exon
1 [LAT(1–661)], which completely contains this miRNA, has
little or no anti-apoptosis activity in transient transfection
assays. In addition, a mutant virus (LAT2.5A) expressing only
this region of LAT has a low, LAT(−)-like reactivation phe-
notype (Inman et al., 2001). Finally, dLAT371, a mutant deleted
from LAT nts 76–447 which includes a critical portion of the
miRNA, has a wild type reactivation phenotype (Perng et al.,
1996b). Interestingly, and in contrast, a mutant deleted for the
same region but expressing only the first 1.5 kb of LAT has a
low LAT(−)-like reactivation phenotype (Perng et al., 1999)
and the corresponding LAT plasmid does not block apoptosis in
transient transfection assays (Jin et al., 2003) suggesting that
the region containing the miRNA is more important in this
context. These previous findings strongly suggest that LAT has
multiple functional domains and that the LAT miRNA
described by Gupta et al. contributes to, but is not sufficient
for, or in the context of the entire LAT transcript, essential for,
LAT's function.
In conclusion, these stable cell lines expressing LAT,
especially when used in conjunction with cold shock, should
be a useful model for further detailed investigation of LAT's
effects on apoptosis.
Materials and methods
Plasmids
A 3586 bp NotI–NotI DNA restriction fragment from
HSV-1 strain 17 syn+ (HSV-1 DNA nts 118,440 to 122,026)
(McGeoch et al., 1988; Perry and McGeoch, 1988) was
cloned into the NotI site of the plasmid pSL301 (Invitrogen)
using standard methods. This plasmid was designated
pLNotI. A second plasmid, designated pLNotIΔPstI, was
derived from pLNotI by digestion with PstI to remove a
194 bp PstI–PstI restriction fragment corresponding to LAT
nts −130 to +64. For selection of stably transfected cells, a
SalI–EcoRI DNA fragment containing a G418 resistance
cassette from the plasmid pBAG (Price et al., 1987) was
cloned into SalI–EcoRI sites of the pSL301 vector with
transcription occurring in the direction opposite to that of
LAT.
Cell lines
Mouse neuroblastoma C1300 cells were grown as mono-
layers in MEM with 10% FCS in a 37 °C incubator with 5%
CO2. C1300 cells were transfected with either 15 μg of pLNotI
or 15 μg of pLNotIΔPstI by lipofectin (Invitrogen) following
17D. Carpenter et al. / Virology 369 (2007) 12–18the manufacturer's standard protocol. Clonal cell lines were
selected with 0.5 mg/ml Geneticin/G418 Sulfate (Gibco BRL)
and grown for 2 weeks before isolation by ring cloning. Cell
numbers were quantitated using a hemacytometer.
Northern blot
Total RNA was extracted from cell lines using TRIzol
Reagent (Invitrogen) following the manufacturer's recommen-
dations. The RNA (10 μg per sample) was separated by
electrophoresis on a 1% agarose formaldehyde denaturing gel
and transferred to Hybond-N+membrane (Amersham). The
blot was hybridized with a 32P-radiolabelled 1805 bp BspMI–
HpaI DNA restriction fragment corresponding to LAT nts +675
to +1499 and visualized on X-ray film.
Cold shock
Cell culture flasks were sealed with Parafilm and placed on
ice for 2 h. The Parafilm was then removed and the cells were
returned to a 37 °C incubator with 5% CO2.
DNA laddering assay
Fragmented chromosomal DNA was isolated from cells
using a hypotonic buffer that lyses the cell without disrupting
the nucleus and allows fragmented but not intact chromosomal
DNA to leave the nucleus, as we previously described (Jin et al.,
2004). DNA laddering was visualized as we previously de-
scribed (Jin et al., 2004).
Western blot
Proteins were extracted in protein extraction buffer
(50 mM Tris–HCl, pH 7.4, 150 mM NaCl, 1% NP-40,
0.25% sodium deoxycholate, 1× protease inhibitor cocktail
[P8340, Sigma-Aldrich, St. Louis, MO], 10 mM NaF, and
1 mM sodium orthovanadate). Proteins (30ug per lane) were
separated on 4–20% precast gels (Invitrogen) by SDS-PAGE
and then transferred to polyvinylidene fluoride (PVDF)
membrane (Millipore Corporation, Bedford, MA). Anti-
cleaved caspase 3 (Asp175) and anti-GAPDH (14C10)
antibodies were purchased from Cell Signaling Technology
(Beverly, MA). All primary antibodies were used at a
dilution of 1:1000 in 5% BSA. Primary antibodies were
detected with goat anti-rabbit HRP-conjugated secondary
antibody (dilution 1:1,000) and visualized using SuperSignal
West Pico Chemiluminescent Substrate (Pierce, Rockford, IL)
and X-ray film.
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